President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was ...

The study's objective is to compare the number of serious adverse events for generic drugs based on manufacturing location.

Ottawa, Precedence Research, April 16, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide generic drugs market size was valued at USD 445.62 billion in 2024 and is projected ...

A FDA generic drug office was eliminated — and the implications will be felt not only by drugmakers, but consumers ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and even a stall in research and development.

The news has been welcomed by healthcare activists and patients as a significant development ... would allow the manufacture of the generic version of the drug and ensure procurement of medicine ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...